Confirmation cell-based assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). The purpose of this assay is to confirm activity of compounds identified as active in a previous set of experiments entitled, "Primary HTS Assay for S1P3 Antagonists," (PubChem AID 485). In this assay, a CHO cell line containing human S1P3 and the beta-lactamase (BLA) reporter-gene under the control of the nuclear factor of activated T-cells (NFAT) promoter was used to measure S1P3 antagonism by test compound. Stimulation of S1P3 by S1P induces transcription of NFAT-BLA via a G-alpha16 protein coupled signaling cascade, and an increase in BLA activity. BLA activity is measured using a BLA FRET substrate. As designed, a compound that acts as a S1P3 antagonist will decrease well FRET.  Compounds were tested in triplicate. Protocol Summary: Cells were cultured in T-175 sq cm flasks at 37 degrees C and 95% relative humidity (RH). The growth media consisted of Dulbecco's Modified Eagle's Media (DMEM) containing 10% v/v heat inactivated bovine growth serum 0.1 mM NEAA, 1 mM sodium pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 2 mg/mL Geneticin, 0.2 mg/mL Hygromycin B and 1x penicillin-streptomycin-neomycin.  Prior to the start of the assay, cells were suspended at a concentration of 1.25 million/mL in phenol red-free DMEM supplemented as above, except with 0.5% charcoal/dextran-treated fetal bovine serum and without antibiotics. The assay was started by dispensing 4 microliters of cell suspension to each well, followed by overnight incubation at 37 degrees C in 5% CO2 and 95% RH.  The next day, 25 nL of test compound (5 uM final nominal concentration) in DMSO was added to sample wells, and DMSO alone (0.5 % final concentration) was added to High Control wells. Next, S1P (0.8 uM final nominal concentration) prepared in 1% fatty-acid free BSA was added to the appropriate wells.  After 4 hours of incubation, 1 ul/well of the GeneBLAzer fluorescent substrate mixture, prepared according to the manufacturer's protocol and containing 10 mM Probenicid, was added to all wells.  The plates were then incubated for 2 hours at room temperature.  Plates were read on the EnVision plate reader at an excitation wavelength of 405 nm and emission wavelengths of 535 nm and 460 nm. Prior to normalization data were corrected by subtracting "background" (ie, fluorescence values from wells containing media and substrate only). To normalize assay data, these corrected values were used to calculate a ratio for each well, according to the following mathematical expression: Ratio = I460 nm/ I535 nm where I represents the measured fluorescence emission intensity at the enumerated wavelength. Percent inhibition was calculated from the median ratio as follows: % Inhibition = 100*(1-((Ratio_Test_Compound - Median_Ratio_High_Control) / (Median_Ratio_Low_Control - Median_Ratio_High_Control))) Where: Test_Compound is defined as wells containing test compound and S1P, Low_Control is defined as wells containing S1P, High_Control is defined as wells containing DMSO Any compound that exhibited a percent inhibition greater than the hit cutoff calculated for the primary screen was declared active.  The reported PubChem Activity Score has been normalized to 100% of the highest observed primary inhibition value. Negative % inhibition values are reported as activity score zero. The inactive compounds of this assay have activity score range of 0 to 23 and active compounds range of activity score is 23 to 100. List of Reagents: Dulbecco's Modified Eagle's Media (Invitrogen, part 11965-092) Bovine Growth Serum (Hyclone, part SH30541.03) NEAA (Invitrogen, part 1114-050) Sodium Pyruvate (Invitrogen, part 11360-070) HEPES (Invitrogen, part 15630-080) L-Glutamine (Invitrogen, part 25030-081) Hygromycin B (Invitrogen, part 10687-010) Geneticin (Invitrogen, part 10131-027) Penicillin-Streptomycin-Neomycin antibiotic mix (Invitrogen part 15140-055) Dulbecco's Modified Eagle#s Media (Invitrogen, part 21063-029) Charcoal/dextran-treated Fetal Bovine Serum (Hyclone, part SH30068.03) S1P (Biomol, part SL140-0001) Fatty Acid Free BSA (JHR, part 85041) GeneBLAzer Fluorescent Substrate Mixture (Invitrogen, part K1085) Probenecid (Sigma, part P8761) 1536-well Plates (Greiner, part 789072) T175 tissue culture flasks (Corning, part 431080)
bao:BAO_0000540 "485" ; # "is confirmatory assay of" -> "485"
bao:BAO_0000812 "1820" ; # "has summary assay" -> "1820"
bao:BAO_0000809 bao:BAO_0000030 ; # "has confirmatory assay" -> "confirmatory assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "beta lactamase reporter gene" ; # "is bioassay type of" -> "beta lactamase reporter gene"
bao:BAO_0000212 bao:BAO_0000125 ; # "has assay method" -> "reporter gene method"
bao:BAO_0000212 bao:BAO_0000151 ; # "has assay method" -> "beta lactamase induction"
bao:BAO_0000207 bao:BAO_0000001 ; # "has detection method" -> "fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3)" ; # "screening campaign name" -> "Antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3)"
bao:BAO_0002853 "Confirmation cell-based assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3)" ; # "has assay title" -> "Confirmation cell-based assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3)"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
bao:BAO_0002833 "4 hour" ; # "has incubation time value" -> "4 hour"
bao:BAO_0002857 bao:BAO_0000118 ; # "has signal direction" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000156 ; # "has assay control" -> "high signal control"
bao:BAO_0002857 "Sphingosine 1-phosphate EC80" ; # "has signal direction" -> "Sphingosine 1-phosphate EC80"
bao:BAO_0000740 bao:BAO_0000168 ; # "has assay control" -> "low signal control"
bao:BAO_0000740 "cell-free wells with media and substrate" ; # "has assay control" -> "cell-free wells with media and substrate"
bao:BAO_0000740 bao:BAO_0000334 ; # "has assay control" -> "background control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Hugh Rosen" ; # "material entity assay provider" -> "Hugh Rosen" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0000118 "0.50%" ; # "DMSO" -> "0.50%"
bao:BAO_0002000 bao:BAO_0000998 ; # "has measured entity" -> "Probenecid" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BAO_0002000 "Sphingosine-1-phosphate" ; # "has measured entity" -> "Sphingosine-1-phosphate" || bao:BAO_0003102 bao:BAO_00020138 ; # "has role" -> "potentiator"
bao:BA0_0090012 "Sphingosine 1-phosphate receptor 3" ; # "has participant" -> "Sphingosine 1-phosphate receptor 3"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0002421> ; # "has cell line" -> "CHO cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Q99500" ; # "uniprot ID" -> "Q99500"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% v/v heat inactivated bovine growth serum" ; # "material entity culture serum" -> "10% v/v heat inactivated bovine growth serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"DMEM with 10% v/v heat inactivated bovine growth serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 2 mg/ml Geneticin, 0.2 mg/ml Hygromycin B and 1x penicillin-streptomycin\"" ; # "material entity culture medium" -> ""DMEM with 10% v/v heat inactivated bovine growth serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 2 mg/ml Geneticin, 0.2 mg/ml Hygromycin B and 1x penicillin-streptomycin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "\"Phenol red free DMEM with 0.5% charcoal/dextran treated fetal bovine serum, 0.1 mM NEAA, 1 mM sodium pyruvate, 25 mM HEPES, 5 mM L-Glutamine\"" ; # "has assay medium" -> ""Phenol red free DMEM with 0.5% charcoal/dextran treated fetal bovine serum, 0.1 mM NEAA, 1 mM sodium pyruvate, 25 mM HEPES, 5 mM L-Glutamine""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "0.5% charcoal/dextran treated fetal bovine serum" ; # "material entity assay serum" -> "0.5% charcoal/dextran treated fetal bovine serum"
bao:BAO_0002923 bao:BAO_0002597 ; # "has assay serum" -> "assay serum"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "Expressing human S1P3 receptor and a beta-lactamase (BLA) reporter gene under the control of a NFAT promoter" ; # "DNA construct" -> "Expressing human S1P3 receptor and a beta-lactamase (BLA) reporter gene under the control of a NFAT promoter"
bao:BAO_0003105 "sphingosine-1-phosphate receptor 3" ; # "has function" -> "sphingosine-1-phosphate receptor 3"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1903" ; # "construct gene ID" -> "1903"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0003105 bao:BAO_00020151 ; # "has function" -> "artificial regulatory region"
bao:BAO_0003105 "Nuclear factor of activated T-cells" ; # "has function" -> "Nuclear factor of activated T-cells"
bao:BAO_0003105 bao:BAO_0000751 ; # "has function" -> "Beta-lactamase" || bao:BAO_0003102 bao:BAO_0002656 ; # "has role" -> "reporter gene"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000751 ; # "has participant" -> "Beta-lactamase"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000923 ; # "has assay kit" -> "GeneBLAzer"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000677 ; # "has manufacturer" -> "Invitrogen" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000701 ; # "uses detection instrument" -> "EnVision Multilabel Reader"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "405 nanometer" ; # "has excitation wavelength value" -> "405 nanometer"
bao:BAO_0002918 "460 nanometer" ; # "has emission wavelength value" -> "460 nanometer"
bao:BAO_0002918 "590 nanometer" ; # "has emission wavelength value" -> "590 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1" ; # "PubChem TID" -> "1"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "4.98" ; # "has concentration value" -> "4.98"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0002845 "3" ; # "has repetition point-number" -> "3"
bao:BAO_0000196 bao:BAO_0000441 ; # "has mode of action" -> "competitive binding"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
